Healthcare is a major benefit in attracting employees, but the rising costs serve as a barrier for small employers that already have a more difficult time competing for workers.
The percentage of Black Americans who lack medical insurance has dropped substantially since the adoption of the Affordable Care Act, but that progress largely depends on where people live, according to a new report from HHS.
Tech companies looking to overhaul the health insurance industry have made much-hyped entries onto the public market. But they have yet to prove they can make money in the long run.
A long-awaited bill to fix the nation's deteriorating mail service is on the verge of passage in the Senate, but it could come at the expense of an even bigger and more complicated problem: Medicare solvency.
On the one hand, the efficacy of Aduhelm is unproven; patients face serious risks; and the drug's FDA approval was extremely controversial, so Medicare officials faced a real dilemma. On the other hand, what would have been the implications if clinical trials had clearly demonstrated that the drug could slow cognitive decline and Biogen had kept the price at $56,000 per year?